lobbying_activities: 3232477

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3232477	f4c76a4d-4bff-4b2c-87fe-c5d2dea84611	3T	WILLIAMS AND JENSEN, PLLC	41454	MT PHARMA AMERICA, INC.	2024	third_quarter	MMM	Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases; matters affecting infusion therapies. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	1	2024-10-04T11:16:14-04:00